<noframes id="zd9f3">

    <address id="zd9f3"></address>

    <address id="zd9f3"></address>
    <address id="zd9f3"></address>

    <address id="zd9f3"><nobr id="zd9f3"><meter id="zd9f3"></meter></nobr></address>
    1. Cell Cycle/DNA Damage
    2. Checkpoint Kinase (Chk)

    Checkpoint Kinase (Chk)

    Checkpoint Kinases (Chk) are protein kinases that are involved in cell cycle control. Two checkpoint kinase subtypes have been identified, Chk1 and Chk2. Chk1 is a central component of genome surveillance pathways and is a key regulator of the cell cycle and cell survival. Chk1 is required for the initiation of DNA damage checkpoints and has recently been shown to play a role in the normal (unperturbed) cell cycle. Chk1 impacts various stages of the cell cycle including the S phase, G2/M transition and M phase. In addition to mediating cell cycle checkpoints, Chk1 also contributes to DNA repair processes, gene transcription, embryo development, cellular responses to HIV infection and somatic cell viability. Chk2 is a protein kinase that is activated in response to DNA damage and is involved in cell cycle arrest. In response to DNA damage and replication blocks, cell cycle progression is halted through the control of cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor.

    Checkpoint Kinase (Chk) Isoform Specific Products:

    • Chk1

    • Chk2

    Checkpoint Kinase (Chk) 相关产品 (18):

    Cat. No. Product Name Effect Purity
    • HY-18174
      Prexasertib Inhibitor
      Prexasertib (LY2606368) 是一种有效,选择性, ATP 竞争性的 Chk1 抑制剂,KiIC50 分别为 <1 nM 和 0.9 nM。
    • HY-10992
      AZD-7762 Inhibitor 98.68%
      AZD-7762 是一种有效的ATP竞争性的细胞周期检测点激酶 (checkpoint kinase,Chk) 抑制剂,抑制Chk1的 IC50 为 5 nM。
    • HY-14720
      Rabusertib Inhibitor 99.61%
      Rabusertib (LY2603618) 是一种有效的选择性的 Chk1 抑制剂,IC50 为 7 nM。
    • HY-18958
      CCT245737 Inhibitor 99.24%
      CCT245737 是一种可口服的,选择性的 Chk1 抑制剂,IC50 值为 1.3 nM。
    • HY-18174A
      Prexasertib dihydrochloride Inhibitor 99.41%
      Prexasertib dihydrochloride (LY2606368 dihydrochloride) 是一种有效的,选择性的,ATP 竞争性的 Chk1 抑制剂,Ki 值为 0.9 nM,对 CHK1 和 CHK2 的 IC50 值分别为 <1 nM 和 8 nM。
    • HY-18174B
      Prexasertib Mesylate Hydrate Inhibitor
      Prexasertib Mesylate Hydrate (LY2606368 Mesylate Hydrate) 是一种有效、选择性、 ATP 竞争性的 CHK1CHK2 抑制剂,对 CHK1 的 Ki 值为 0.9 nM,IC50 值 <1 nM,对 CHK2 的 IC50 值为 8 nM。Prexasertib Mesylate Hydrate 抑制 HT-2
    • HY-111369
      CHK1-IN-2 Inhibitor
      CHK1-IN-2 是细胞周期检测点激酶 (CHK1) 的抑制剂,其 IC50 为 6 nM。
    • HY-14715B
      CCT241533 hydrochloride Inhibitor 99.62%
      CCT241533 hydrochloride是有效,选择性的 CHK2 抑制剂,IC50Ki 分别为3 nM 和1.16 nM。
    • HY-13263
      CHIR-124 Inhibitor 98.77%
      CHIR-124 是一种有效的,选择性的 Chk1 抑制剂,IC50 值为 0.3 nM;同时可有效抑制 PDGFRFLT3IC50 值分别为 6.6 nM 和 5.8 nM。
    • HY-15532
      SCH900776 Inhibitor 99.65%
      SCH900776 是一种有效,选择性,可口服的 Chk1 抑制剂,IC50 值为 3 nM;它比对CDK2 和 Chk2 的选择性分别高50和500倍。
    • HY-13946
      BML-277 Inhibitor
      BML-277 是一种选择性的检测点激酶 2 (Chk2) 抑制剂,IC50 为 15 nM。
    • HY-10032
      PF 477736 Inhibitor 98.04%
      PF 477736 是一种有效的,ATP 竞争性的 Chk1 抑制剂,Ki 为 0.49 nM,对其选择性是 Chk2 (Ki, 47 nM) 的 100 倍。
    • HY-18175
      CCT244747 Inhibitor 98.03%
      CCT244747 是一种有效的,可口服的,高度选择性的 CHK1 抑制剂,IC50 值为 7.7 nM;CCT244747 可废除 G2 检查点,IC50 值为 29 nM。
    • HY-112167
      GDC-0575 Inhibitor >98.0%
      GDC-0575 (ARRY-575, RG7741) 是高选择性,有口服活性的小分子 Chk1 抑制剂,其在异种移植模型中导致肿瘤缩小和生长延迟,IC50 值为1.2?nM。
    • HY-112167A
      GDC-0575 dihydrochloride Inhibitor 99.32%
      GDC-0575 dihydrochloride 是一种选择性的,可口服的 CHK1 抑制剂,IC50 值为 1.2 nM,具有抗肿瘤活性。
    • HY-14715
      CCT241533 Inhibitor
      CCT241533是高活性丝氨酸/苏氨酸Chk2抑制剂,IC50为3 nM,与其它激酶有极小的交叉反应(1 uM)。
    • HY-104022
      CHK1 inhibitor Inhibitor
      CHK1 inhibitor 是 CHK1 的抑制剂。
    • HY-U00345
      CHK-IN-1 Inhibitor
      CHK-IN-1 是一种 CHK1CHK2 的抑制剂,具有抗增殖作用。
    Isoform Specific Products

    Your Search Returned No Results.

    Sorry. There is currently no product that acts on isoform together.

    Please try each isoform separately.